Nishitha M. Reddy

Learn More
We sought to establish clinical practice recommendations to redefine the role of allogeneic hematopoietic cell transplantation (allo-HCT) for patients with chronic lymphocytic leukemia (CLL) in an(More)
TPS138 Background: Approximately 40% patients with an intermediate/high to high-risk IPI score will relapse in the first year after completion of standard therapy with R-CHOP. Lenalidomide, an(More)